Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 831 entries
Sorted by: Best Match Show Resources per page
Literature review on the use of action research in higher education

Louis Stokes Alliances for Minority Participation AND Program Evaluation

Gibbs P.
GSID: 5aHf0T8n_xUJ
P Gibbs, P Cartney, K Wilkinson… - Educational Action …, 2017 - Taylor & Francis

This literature review considers the use of action research in higher education. The review specifically looks at two areas of higher education activity. The first concerns academic teaching practice and includes a discussion of research and pedagogy practice, and...

Cite
Gibbs, P., Cartney, P., Wilkinson, K., Parkinson, J., Cunningham, S., James-Reynolds, C., ... & Pitt, A. (2017). Literature review on the use of action research in higher education. Educational Action Research, 25(1), 3-22.
Gibbs, Paul, et al. "Literature review on the use of action research in higher education." Educational Action Research 25.1 (2017): 3-22.
Copy Download .nbib Format: MLA
Stigma, gender and HIV: case studies of inter-sectionality

case studies

Campbell C, Gibbs A.
GSID: 3SscmhMxtl0J
C Campbell, A Gibbs - Gender and HIV/AIDS, 2016 - taylorfrancis.com

… Our final case study is drawn from South Africa. The two case studies we have discussed above have boasted some successes along the lines of Wieck’s “small wins,” or Scheyven’s “subtle empowerment strategies.” In contrast, the mobilization of...

Cite
Campbell, C., & Gibbs, A. (2016). Stigma, gender and HIV: case studies of inter-sectionality. In Gender and HIV/AIDS (pp. 29-46). Routledge.
Campbell, Catherine, and Andrew Gibbs. "Stigma, gender and HIV: case studies of inter-sectionality." Gender and HIV/AIDS. Routledge, 2016. 29-46.
Copy Download .nbib Format: MLA
Methods for the evaluation of the Jamie Oliver Ministry of Food program, Australia

Science interventions

Gibbs L, Keating C.
GSID: tAHoGcWBA0gJ
A Flego, J Herbert, L Gibbs, B Swinburn, C Keating… - BMC Public Health, 2013 - Springer

Community-based programs aimed at improving cooking skills, cookingconfidence and individual eating behaviours have grown in number over thepast two decades. Whilst some …

Cite
Flego, A., Herbert, J., Gibbs, L., Swinburn, B., Keating, C., Waters, E., & Moodie, M. (2013). Methods for the evaluation of the Jamie Oliver Ministry of Food program, Australia. BMC Public Health, 13(1), 1-8.
Flego, Anna, et al. "Methods for the evaluation of the Jamie Oliver Ministry of Food program, Australia." BMC Public Health 13.1 (2013): 1-8.
Copy Download .nbib Format: MLA
AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software.

F1000Research

Weiss SA, Asadi-Pooya AA, Vangala S, Moy S, Wyeth DH, Orosz I, Gibbs M, Schrader L, Lerner J, Cheng CK, Chang E, Rajaraman R, Keselman I, Churchman P, Bower-Baca C, Numis AL, Ho MG, Rao L, Bhat A, Suski J, Asadollahi M, Ambrose T, Fernandez A, Nei M, Skidmore C, Mintzer S, Eliashiv DS, Mathern GW, Nuwer MR, Sperling M, Engel J, Stern JM.
PMID: 28491280
F1000Res. 2017 Jan 10;6:30. doi: 10.12688/f1000research.10569.2. eCollection 2017.

No abstract available.

Cite
Weiss SA, Asadi-Pooya AA, Vangala S, et al. AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software. F1000Res. 2017;6:30doi: 10.12688/f1000research.10569.2.
Weiss, S. A., Asadi-Pooya, A. A., Vangala, S., Moy, S., Wyeth, D. H., Orosz, I., Gibbs, M., Schrader, L., Lerner, J., Cheng, C. K., Chang, E., Rajaraman, R., Keselman, I., Churchman, P., Bower-Baca, C., Numis, A. L., Ho, M. G., Rao, L., Bhat, A., Suski, J., Asadollahi, M., Ambrose, T., Fernandez, A., Nei, M., Skidmore, C., Mintzer, S., Eliashiv, D. S., Mathern, G. W., Nuwer, M. R., Sperling, M., Engel, J., & Stern, J. M. (2017). AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software. F1000Research, 630. https://doi.org/10.12688/f1000research.10569.2
Weiss, Shennan Aibel, et al. "AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software." F1000Research vol. 6 (2017): 30. doi: https://doi.org/10.12688/f1000research.10569.2
Weiss SA, Asadi-Pooya AA, Vangala S, Moy S, Wyeth DH, Orosz I, Gibbs M, Schrader L, Lerner J, Cheng CK, Chang E, Rajaraman R, Keselman I, Churchman P, Bower-Baca C, Numis AL, Ho MG, Rao L, Bhat A, Suski J, Asadollahi M, Ambrose T, Fernandez A, Nei M, Skidmore C, Mintzer S, Eliashiv DS, Mathern GW, Nuwer MR, Sperling M, Engel J, Stern JM. AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software. F1000Res. 2017 Jan 10;6:30. doi: 10.12688/f1000research.10569.2. eCollection 2017. PMID: 28491280; PMCID: PMC5399961.
Copy Download .nbib Format: NLM
SU-E-T-162: Rapid Assessment of Cyberknife IRIS Variable Collimator Performance Using a Commercial Diode Array.

Medical physics

Gibbs G, White G, Bulz G.
PMID: 28517840
Med Phys. 2012 Jun;39(6):3740. doi: 10.1118/1.4735220.

PURPOSE: To describe an efficient method for verifying the size and centering of the radiation field from the Cyberknife IRIS variable collimator with sub-millimeter accuracy using a general purpose commercially available diode array.METHODS: We present a technique using a...

Cite
Gibbs G, White G, Bulz G. SU-E-T-162: Rapid Assessment of Cyberknife IRIS Variable Collimator Performance Using a Commercial Diode Array. Med Phys. 2012;39(6):3740doi: 10.1118/1.4735220.
Gibbs, G., White, G., & Bulz, G. (2012). SU-E-T-162: Rapid Assessment of Cyberknife IRIS Variable Collimator Performance Using a Commercial Diode Array. Medical physics, 39(6), 3740. https://doi.org/10.1118/1.4735220
Gibbs, G, et al. "SU-E-T-162: Rapid Assessment of Cyberknife IRIS Variable Collimator Performance Using a Commercial Diode Array." Medical physics vol. 39,6 (2012): 3740. doi: https://doi.org/10.1118/1.4735220
Gibbs G, White G, Bulz G. SU-E-T-162: Rapid Assessment of Cyberknife IRIS Variable Collimator Performance Using a Commercial Diode Array. Med Phys. 2012 Jun;39(6):3740. doi: 10.1118/1.4735220. PMID: 28517840.
Copy Download .nbib Format: NLM
Ancient lipids document continuity in the use of early hunter-gatherer pottery through 9,000 years of Japanese prehistory.

Proceedings of the National Academy of Sciences of the United States of America

Lucquin A, Gibbs K, Uchiyama J, Saul H, Ajimoto M, Eley Y, Radini A, Heron CP, Shoda S, Nishida Y, Lundy J, Jordan P, Isaksson S, Craig OE.
PMID: 27001829
Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):3991-6. doi: 10.1073/pnas.1522908113. Epub 2016 Mar 21.

The earliest pots in the world are from East Asia and date to the Late Pleistocene. However, ceramic vessels were only produced in large numbers during the warmer and more stable climatic conditions of the Holocene. It has long...

Cite
Lucquin A, Gibbs K, Uchiyama J, et al. Ancient lipids document continuity in the use of early hunter-gatherer pottery through 9,000 years of Japanese prehistory. Proc Natl Acad Sci U S A. 2016;113(15):3991-6doi: 10.1073/pnas.1522908113.
Lucquin, A., Gibbs, K., Uchiyama, J., Saul, H., Ajimoto, M., Eley, Y., Radini, A., Heron, C. P., Shoda, S., Nishida, Y., Lundy, J., Jordan, P., Isaksson, S., & Craig, O. E. (2016). Ancient lipids document continuity in the use of early hunter-gatherer pottery through 9,000 years of Japanese prehistory. Proceedings of the National Academy of Sciences of the United States of America, 113(15), 3991-6. https://doi.org/10.1073/pnas.1522908113
Lucquin, Alexandre, et al. "Ancient lipids document continuity in the use of early hunter-gatherer pottery through 9,000 years of Japanese prehistory." Proceedings of the National Academy of Sciences of the United States of America vol. 113,15 (2016): 3991-6. doi: https://doi.org/10.1073/pnas.1522908113
Lucquin A, Gibbs K, Uchiyama J, Saul H, Ajimoto M, Eley Y, Radini A, Heron CP, Shoda S, Nishida Y, Lundy J, Jordan P, Isaksson S, Craig OE. Ancient lipids document continuity in the use of early hunter-gatherer pottery through 9,000 years of Japanese prehistory. Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):3991-6. doi: 10.1073/pnas.1522908113. Epub 2016 Mar 21. PMID: 27001829; PMCID: PMC4839459.
Copy Download .nbib Format: NLM
Reversing factor Xa inhibitors - clinical utility of andexanet alfa.

Journal of blood medicine

Kaatz S, Bhansali H, Gibbs J, Lavender R, Mahan CE, Paje DG.
PMID: 28979172
J Blood Med. 2017 Sep 13;8:141-149. doi: 10.2147/JBM.S121550. eCollection 2017.

Approximately half of patients started on an oral anticoagulant in the USA now receive one of the newer direct oral anticoagulants (DOACs). Although there is an approved reversal agent for the direct thrombin inhibitor dabigatran, a specific reversal agent...

Cite
Kaatz S, Bhansali H, Gibbs J, et al. Reversing factor Xa inhibitors - clinical utility of andexanet alfa. J Blood Med. 2017;8:141-149doi: 10.2147/JBM.S121550.
Kaatz, S., Bhansali, H., Gibbs, J., Lavender, R., Mahan, C. E., & Paje, D. G. (2017). Reversing factor Xa inhibitors - clinical utility of andexanet alfa. Journal of blood medicine, 8141-149. https://doi.org/10.2147/JBM.S121550
Kaatz, Scott, et al. "Reversing factor Xa inhibitors - clinical utility of andexanet alfa." Journal of blood medicine vol. 8 (2017): 141-149. doi: https://doi.org/10.2147/JBM.S121550
Kaatz S, Bhansali H, Gibbs J, Lavender R, Mahan CE, Paje DG. Reversing factor Xa inhibitors - clinical utility of andexanet alfa. J Blood Med. 2017 Sep 13;8:141-149. doi: 10.2147/JBM.S121550. eCollection 2017. PMID: 28979172; PMCID: PMC5602457.
Copy Download .nbib Format: NLM
Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.

JMIR research protocols

Virdee PS, Moschandreas J, Gebski V, Love SB, Francis EA, Wasan HS, van Hazel G, Gibbs P, Sharma RA.
PMID: 28351831
JMIR Res Protoc. 2017 Mar 28;6(3):e43. doi: 10.2196/resprot.7201.

BACKGROUND: In colorectal cancer (CRC), unresectable liver metastases are associated with a poor prognosis. The FOXFIRE (an open-label randomized phase III trial of 5-fluorouracil, oxaliplatin, and folinic acid +/- interventional radioembolization as first-line treatment for patients with unresectable liver-only...

Cite
Virdee PS, Moschandreas J, Gebski V, et al. Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer. JMIR Res Protoc. 2017;6(3):e43doi: 10.2196/resprot.7201.
Virdee, P. S., Moschandreas, J., Gebski, V., Love, S. B., Francis, E. A., Wasan, H. S., van Hazel, G., Gibbs, P., & Sharma, R. A. (2017). Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer. JMIR research protocols, 6(3), e43. https://doi.org/10.2196/resprot.7201
Virdee, Pradeep S, et al. "Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer." JMIR research protocols vol. 6,3 (2017): e43. doi: https://doi.org/10.2196/resprot.7201
Virdee PS, Moschandreas J, Gebski V, Love SB, Francis EA, Wasan HS, van Hazel G, Gibbs P, Sharma RA. Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer. JMIR Res Protoc. 2017 Mar 28;6(3):e43. doi: 10.2196/resprot.7201. PMID: 28351831; PMCID: PMC5388825.
Copy Download .nbib Format: NLM
NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis.

ISRN hepatology

Nguyen V, Zielinski R, Harnett P, Miller K, Chan H, Vootakuru N, Acharya P, Khan M, Gibbs O, Gupta S, Devi A, Phillips S, George J, van der Poorten D.
PMID: 27335835
ISRN Hepatol. 2013 Sep 22;2013:959474. doi: 10.1155/2013/959474. eCollection 2013.

Background. N-terminal probrain natriuretic peptide (NT-proBNP) is a hormone involved in the regulation of cardiovascular homeostasis. Changes in serum NT-proBNP during large volume paracentesis (LVP) in patients with ascites have never before been examined. Aims. To determine if significant...

Cite
Nguyen V, Zielinski R, Harnett P, et al. NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis. ISRN Hepatol. 2013;2013:959474doi: 10.1155/2013/959474.
Nguyen, V., Zielinski, R., Harnett, P., Miller, K., Chan, H., Vootakuru, N., Acharya, P., Khan, M., Gibbs, O., Gupta, S., Devi, A., Phillips, S., George, J., & van der Poorten, D. (2013). NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis. ISRN hepatology, 2013959474. https://doi.org/10.1155/2013/959474
Nguyen, Vi, et al. "NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis." ISRN hepatology vol. 2013 (2013): 959474. doi: https://doi.org/10.1155/2013/959474
Nguyen V, Zielinski R, Harnett P, Miller K, Chan H, Vootakuru N, Acharya P, Khan M, Gibbs O, Gupta S, Devi A, Phillips S, George J, van der Poorten D. NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis. ISRN Hepatol. 2013 Sep 22;2013:959474. doi: 10.1155/2013/959474. eCollection 2013. PMID: 27335835; PMCID: PMC4890870.
Copy Download .nbib Format: NLM
A proposed new clinical assessment framework for diagnostic medical ultrasound students.

Ultrasound (Leeds, England)

Gibbs V.
PMID: 27433204
Ultrasound. 2014 May;22(2):113-7. doi: 10.1177/1742271X13513224. Epub 2013 Dec 02.

Current financial pressures within higher education institutions (HEIs) are driving new ways of delivering education and assessment. New technological developments are facilitating opportunities to rethink traditional educational methods and explore more innovative, effective approaches. Set against a background of...

Cite
Gibbs V. A proposed new clinical assessment framework for diagnostic medical ultrasound students. Ultrasound. 2013;22(2):113-7doi: 10.1177/1742271X13513224.
Gibbs, V. (2014). A proposed new clinical assessment framework for diagnostic medical ultrasound students. Ultrasound (Leeds, England), 22(2), 113-7. https://doi.org/10.1177/1742271X13513224
Gibbs, Vivien. "A proposed new clinical assessment framework for diagnostic medical ultrasound students." Ultrasound (Leeds, England) vol. 22,2 (2014): 113-7. doi: https://doi.org/10.1177/1742271X13513224
Gibbs V. A proposed new clinical assessment framework for diagnostic medical ultrasound students. Ultrasound. 2014 May;22(2):113-7. doi: 10.1177/1742271X13513224. Epub 2013 Dec 02. PMID: 27433204; PMCID: PMC4760540.
Copy Download .nbib Format: NLM
Feasibility of Imaging Tissue Electrical Conductivity by Switching Field Gradients with MRI.

Tomography (Ann Arbor, Mich.)

Gibbs E, Liu C.
PMID: 26844302
Tomography. 2015 Dec;1(2):125-135. doi: 10.18383/j.tom.2015.00142.

Tissue conductivity is a biophysical marker of tissue structure and physiology. Present methods of measuring tissue conductivity are limited. Electrical impedance tomography, and magnetic resonance electrical impedance tomography rely on passing external current through the object being imaged, which...

Cite
Gibbs E, Liu C. Feasibility of Imaging Tissue Electrical Conductivity by Switching Field Gradients with MRI. Tomography. 2015;1(2):125-135doi: 10.18383/j.tom.2015.00142.
Gibbs, E., & Liu, C. (2015). Feasibility of Imaging Tissue Electrical Conductivity by Switching Field Gradients with MRI. Tomography (Ann Arbor, Mich.), 1(2), 125-135. https://doi.org/10.18383/j.tom.2015.00142
Gibbs, Eric, and Liu, Chunlei. "Feasibility of Imaging Tissue Electrical Conductivity by Switching Field Gradients with MRI." Tomography (Ann Arbor, Mich.) vol. 1,2 (2015): 125-135. doi: https://doi.org/10.18383/j.tom.2015.00142
Gibbs E, Liu C. Feasibility of Imaging Tissue Electrical Conductivity by Switching Field Gradients with MRI. Tomography. 2015 Dec;1(2):125-135. doi: 10.18383/j.tom.2015.00142. PMID: 26844302; PMCID: PMC4734905.
Copy Download .nbib Format: NLM
Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients.

Journal of cancer epidemiology

Bae S, Wong HL, Tie J, Desai J, Field K, Kosmider S, Fourlanos S, Jones I, Skinner I, Gibbs P.
PMID: 26074965
J Cancer Epidemiol. 2015;2015:189132. doi: 10.1155/2015/189132. Epub 2015 May 05.

Diabetes is a risk factor for colorectal cancer and several reports suggest worse cancer-specific outcomes in diabetes patients. Recent studies in multiple tumour types indicate metformin may positively impact on cancer-specific and overall survival. A population-based series of stage...

Cite
Bae S, Wong HL, Tie J, et al. Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients. J Cancer Epidemiol. 2015;2015:189132doi: 10.1155/2015/189132.
Bae, S., Wong, H. L., Tie, J., Desai, J., Field, K., Kosmider, S., Fourlanos, S., Jones, I., Skinner, I., & Gibbs, P. (2015). Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients. Journal of cancer epidemiology, 2015189132. https://doi.org/10.1155/2015/189132
Bae, Susie, et al. "Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients." Journal of cancer epidemiology vol. 2015 (2015): 189132. doi: https://doi.org/10.1155/2015/189132
Bae S, Wong HL, Tie J, Desai J, Field K, Kosmider S, Fourlanos S, Jones I, Skinner I, Gibbs P. Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients. J Cancer Epidemiol. 2015;2015:189132. doi: 10.1155/2015/189132. Epub 2015 May 05. PMID: 26074965; PMCID: PMC4436511.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 831 entries